Results 101 to 110 of about 523,881 (183)

Ultrafast dynamic stark shift of an exciton-polariton condensate. [PDF]

Nat Commun
Feldman S, Panna D, Landau N, Brodbeck S, Klembt S, Schneider C, Höfling S, Hayat A.   +7 more
europepmc   +1 more source

Immunotherapy impact of macrophage glycosylation on cholangiocarcinoma and its prognostic and immune microenvironment significance. [PDF]

Hum Vaccin Immunother
Xu Y, Xu X, Xu Y, Duan J.
europepmc   +1 more source

Development and validation of a collagen signature to predict central lymph node metastasis in papillary thyroid cancer. [PDF]

Front Endocrinol (Lausanne)
Chen W, Ge J, Luo T, Dong S, Jiang W, Wu C, Ye B, Zhang D, He W, Yan J, Lei S.   +10 more
europepmc   +1 more source

Integrating WGCNA and machine learning algorithm to identify ACSM5 as a prognostic biomarker and therapeutic target for predicting immunotherapy efficacy in non-small cell lung cancer. [PDF]

Transl Cancer Res
Ma X, Du W, Bai M, Dai Z.
europepmc   +1 more source

StarSignDNA: mutation-to-signature attribution for accurate representation of mutational processes in low-mutation contexts. [PDF]

NAR Genom Bioinform
Bope CD, Kalyanasundaram S, Rand KD, Nakken S, Lingjærde OC, Hovig E.   +5 more
europepmc   +1 more source

Immune Unresponsiveness to Cardiopulmonary Bypass Is Associated With Unfavorable Outcome in Infants Requiring Cardiac Surgery. [PDF]

JACC Basic Transl Sci
Chenouard A, Petrier M, Bridonneau C, André E, Davieau M, Fourgeux C, Mancuso C, Davidson J, Broquet A, Joram N, Bourgoin P, Gourain V, Poschmann J, Jacqueline C, Roquilly A.   +14 more
europepmc   +1 more source

A novel gene signature based on Like-Smith family members-related genes for predicting the prognosis of hepatocellular carcinoma. [PDF]

Transl Cancer Res
Chen S, Chen X, Sun X, Wu S.
europepmc   +1 more source

Tumor mutational burden predicts neoantigen profiles and immunotherapy response in microsatellite stable tumors across different cancer types. [PDF]

Front Immunol
Kondrateva O, Sonay TB, Zlobec I, Anisimova M.   +3 more
europepmc   +1 more source